ArticleJournal of cardiac failure2026

Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.

Olives Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.